Savara Inc. (SVRA)

Savara Inc. (SVRA) is a healthcare company (biotechnology) based in the United States. The share price is $4.49, up 0.45% on the day, which values the company at $989.5M. Price as of 17 Nov 2026, 18:24 UTC, from Yahoo Finance.

Key facts

Share price
$4.49+0.45% today
Market value
$989.5M
200-week average
$3.9912% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Savara Inc. in more detail

SVRA trades at -12.1× next year's expected earnings. It sits 12% above its 200-week average of $3.99.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

1 of the superinvestors tracked here hold SVRA, including Anthony Bozza (0.0% of the portfolio).

Superinvestors holding SVRA

1 of the investors tracked here report a position in their latest 13F filing.

Savara Inc. (SVRA): questions and answers

What is Savara Inc.'s market cap?

Savara Inc. is valued at $989.5M at a share price of $4.49.

Is SVRA above its 200-week moving average?

Yes. SVRA is 12.4% above its 200-week average of $3.99. Long-term investors watch that line because strong companies rarely trade below it for long.

Does SVRA pay a dividend?

Savara Inc. does not currently pay a regular dividend.

Which famous investors own SVRA?

In their latest quarterly filings, Anthony Bozza (0.0% of the portfolio) hold SVRA. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Savara Inc. (SVRA) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/SVRA

Underlying data: Yahoo Finance; company filings with the SEC.